99.6k views
1 vote
What is the enzyme that catalyzes the conversion of HMG-CoA to Mevalonate and is the target for statins?

User Relliv
by
8.3k points

1 Answer

3 votes

Final answer:

HMG-CoA reductase is the enzyme that catalyzes the conversion of HMG-CoA to Mevalonate and is the target for statins, which are drugs designed to reduce cholesterol synthesis in the body.

Step-by-step explanation:

The enzyme that catalyzes the conversion of HMG-CoA to Mevalonate is HMG-CoA reductase, which is a crucial target for the class of drugs known as statins. The production of cholesterol in the body involves several steps, starting with the combination of two molecules of acetyl-CoA to eventually form HMG-CoA. HMG-CoA reductase then catalyzes the conversion of HMG-CoA to Mevalonate, which is the rate-limiting step in this biosynthetic pathway.

Statins function by inhibiting HMG-CoA reductase, thus leading to reduced cholesterol synthesis. This is instrumental in managing high cholesterol levels and associated disorders such as cardiovascular disease. The development of statins involved identifying HMG-CoA reductase as the target molecule and creating a drug capable of inhibiting its action, leading to subsequent in vitro and clinical trials before gaining FDA approval.

User Philraj
by
8.0k points
Welcome to QAmmunity.org, where you can ask questions and receive answers from other members of our community.